EasySep™小鼠TIL（CD45）正选试剂盒
产品号 #72552_C
WNT 通路抑制剂；抑制豪猪蛋白 (Porcupine)
若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系
总览
WNT 生成抑制剂 4 (IWP-4) 通过抑制豪猪蛋白 (Porcupine) 来抑制 WNT 信号传导。豪猪蛋白是一种膜结合 O-酰基转移酶，负责对 WNT 蛋白进行棕榈酰化，而棕榈酰化对 WNT 信号传导能力和分泌至关重要（Chen et al.）。IWP-4 在体外可抑制 WNT 通路活性，IC50 值为 25 nM（Chen et al.）。
分化
·经 CHIR99021 处理后，可促进人多能干细胞向心肌细胞分化 (Lian et al., 2012, 2013; Sequiera et al.)。
·用BMP4和激活素A诱导原条（primitive streak）后，促进人胚胎干细胞向心肌细胞分化（Hudson et al.）。
细胞类型
心肌细胞，PSC衍生，多能干细胞
种属
人，小鼠，非人灵长类，其它细胞系，大鼠
应用
分化
研究领域
干细胞生物学
CAS 编号
686772-17-8
化学式
C₂₃H₂₀N₄O₃S₃
纯度
≥ 95 %
通路
WNT
靶点
Porcupine
产品说明书及文档
请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。
应用领域
本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。
相关材料与文献
技术资料 (3)
文献 (9)
A Simple Protocol for the Generation of Cardiomyocytes from Human Pluripotent Stem Cells. Methods in molecular biology (Clifton, N.J.) 2016 JAN
Abstract
Efficient generation of cardiomyocytes from pluripotent stem cells (PSCs) for multiple downstream applications such as regenerative medicine, disease modeling, and drug screening remains a challenge. Cardiomyogenesis may be regulated in vitro by a controlled differentiation process, which involves various signaling molecules and extracellular environment. Here, we describe a simple method to efficiently generate cardiomyocytes from human embryonic stem cells and human induced pluripotent stem cells.
Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons. Stem cell reviews 2014 APR
Abstract
Here we provide a protocol for the directed differentiation of hEPI-NCSC into midbrain dopaminergic neurons, which degenerate in Parkinson's disease. hEPI-NCSC are neural crest-derived multipotent stem cells that persist into adulthood in the bulge of hair follicles. The experimental design is distinctly different from conventional protocols for embryonic stem cells and induced pluripotent stem (iPS) cells. It includes pre-differentiation of the multipotent hEPI-NCSC into neural stem cell-like cells, followed by ventralizing, patterning, continued exposure to the TGFβ receptor inhibitor, SB431542, and at later stages of differentiation the presence of the WNT inhibitor, IWP-4. All cells expressed A9 midbrain dopaminergic neuron progenitor markers with gene expression levels comparable to those in normal human substantia nigra. The current study shows for the first time that virtually homogeneous populations of dopaminergic neurons can be derived ex vivo from somatic stem cells without the need for purification, with useful timeliness and high efficacy. This novel development is an important first step towards the establishment of fully functional dopaminergic neurons from an ontologically relevant stem cell type, hEPI-NCSC.
Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nature protocols 2013 JAN
Abstract
The protocol described here efficiently directs human pluripotent stem cells (hPSCs) to functional cardiomyocytes in a completely defined, growth factor- and serum-free system by temporal modulation of regulators of canonical Wnt signaling. Appropriate temporal application of a glycogen synthase kinase 3 (GSK3) inhibitor combined with the expression of β-catenin shRNA or a chemical Wnt inhibitor is sufficient to produce a high yield (0.8-1.3 million cardiomyocytes per cm(2)) of virtually pure (80-98%) functional cardiomyocytes in 14 d from multiple hPSC lines without cell sorting or selection. Qualitative (immunostaining) and quantitative (flow cytometry) characterization of differentiated cells is described to assess the expression of cardiac transcription factors and myofilament proteins. Flow cytometry of BrdU incorporation or Ki67 expression in conjunction with cardiac sarcomere myosin protein expression can be used to determine the proliferative capacity of hPSC-derived cardiomyocytes. Functional human cardiomyocytes differentiated via these protocols may constitute a potential cell source for heart disease modeling, drug screening and cell-based therapeutic applications.
更多信息
| 种属 | Human, Mouse, Non-Human Primate, Other, Rat |
|---|---|
| Cas Number | 686772-17-8 |
| Chemical Formula | C₂₃H₂₀N₄O₃S₃ |
| 纯度 | ≥ 95% |
| Target | Porcupine |
| Pathway | WNT |
相关产品
-
STEMdiff™ 中胚层诱导培养基用于早期中胚层分化的成分明确、无异种成分的诱导培养基
-
CHIR99021WNT 通路激活剂；抑制 GSK3
-
IWP-3WNT 通路抑制剂；抑制豪猪蛋白 (Porcupine)
-
重组人/小鼠激活素A激活素A
